Synthetech develops and produces chiral chemicals, including small molecules, amino acids, and peptide fragments, for applications in pharmaceticals around the world. Founded in 1981, Synthetech has a long history of supplying major pharmaceutical and biotech companies with quality intermediates and raw materials for production of active pharmaceutical ingredients. Originally a publicly traded company, Synthetech became a wholly owned subsidiary of WR Grace on November 18, 2010.